{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:16:15Z","timestamp":1778001375569,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.medcli.2026.107367","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:45:16Z","timestamp":1772747116000},"page":"107367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dermatomiositis amiop\u00e1tica asociada a anticuerpos anti-MDA5 y neumon\u00eda intersticial r\u00e1pidamente progresiva: 2 casos con diferente evoluci\u00f3n cl\u00ednica"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-0350","authenticated-orcid":false,"given":"Freddy","family":"Li\u00f1\u00e1n-Ponce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107367_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: Pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.medcli.2026.107367_bib0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13075-025-03485-z","article-title":"Clinical features and survival analysis of anti-MDA5 antibody-positive dermatomyositis complicated with interstitial lung disease","volume":"27","author":"Zhao","year":"2025","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.medcli.2026.107367_bib0040","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2169\/internalmedicine.2915-23","article-title":"Anti-MDA5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease successfully treated by combined immunodepressive therapy","volume":"63","author":"Yamazoe","year":"2024","journal-title":"Intern Med."},{"key":"10.1016\/j.medcli.2026.107367_bib0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s41927-025-00556-1","article-title":"Clinical characteristics and outcomes of anti-MDA5 dermatomyositis","volume":"9","author":"Sodsri","year":"2025","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.medcli.2026.107367_bib0050","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241294000","article-title":"Efficacy and safety of tofacitinib in anti-MDA5 dermatomyositis-associated interstitial lung disease: systematic review and meta-analysis","volume":"18","author":"Wang","year":"2024","journal-title":"Ther Adv Respir Dis."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:42:16Z","timestamp":1777999336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0025775326000175"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107367","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dermatomiositis amiop\u00e1tica asociada a anticuerpos anti-MDA5 y neumon\u00eda intersticial r\u00e1pidamente progresiva: 2 casos con diferente evoluci\u00f3n cl\u00ednica","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107367"}}